Cargando…
Clinical Benefit from Trametinib in a Patient with Appendiceal Adenocarcinoma with a GNAS R201H Mutation
We report the case of a patient with appendiceal adenocarcinoma with mucinous peritoneal carcinomatosis who was treated with trametinib upon identification of a GNAS R201H mutation by comprehensive genomic profiling. The molecular pathology of appendiceal neoplasms is reviewed, and the mechanistic b...
Autores principales: | Ang, Celina, Stollman, Aryeh, Zhu, Hongfa, Sarpel, Umut, Scarborough, Bethann, Sahni, Gagan, Millis, Sherri Z. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5567127/ https://www.ncbi.nlm.nih.gov/pubmed/28868010 http://dx.doi.org/10.1159/000477562 |
Ejemplares similares
-
Response to trametinib in a nonsmall cell lung cancer patient with osimertinib resistance harboring GNAS R201C and R201H mutations: a case report
por: Lv, You, et al.
Publicado: (2022) -
Frequent GNAS mutations in low-grade appendiceal mucinous neoplasms
por: Nishikawa, G, et al.
Publicado: (2013) -
A unique presentation of superinfected pseudomyxoma peritonei secondary to a low-grade appendiceal mucinous neoplasm
por: Sullivan, Brianne J., et al.
Publicado: (2019) -
ONC201 and an MEK Inhibitor Trametinib Synergistically Inhibit the Growth of Triple-Negative Breast Cancer Cells
por: Lim, Bora, et al.
Publicado: (2021) -
Frequency of GNAS R201H substitution mutation in polyostotic fibrous dysplasia: Pyrosequencing analysis in tissue samples with or without decalcification
por: Shin, Su-Jin, et al.
Publicado: (2017)